Edition:
United States

People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

28.82USD
24 Mar 2017
Change (% chg)

$0.46 (+1.62%)
Prev Close
$28.36
Open
$28.47
Day's High
$29.06
Day's Low
$28.06
Volume
386,383
Avg. Vol
438,599
52-wk High
$44.38
52-wk Low
$24.47

Sullivan, Louis 

The Hon. Dr. Louis W. Sullivan, M.D., is an Independent Director of Emergent BioSolutions Inc. Dr. Sullivan has served as president emeritus of Morehouse School of Medicine since July 2002. Dr. Sullivan served as president of Morehouse School of Medicine from 1981 to 1989 and from 1993 to 2002. From 1989 to 1993, Dr. Sullivan was Secretary of the Department of Health and Human Services. Dr. Sullivan serves on the boards of directors of United Therapeutics Corporation, BioSante Pharmaceuticals and Henry Schein, Inc., all publicly held biotechnology companies. He was a founder and chairman of Medical Education for South African Blacks, Inc., a trustee of Africare, a director of the National Center on Addiction and Substance Abuse at Columbia University and chairman of the board of trustees of the National Health Museum, a non-profit institution developing a museum of health sciences. Dr. Sullivan received his M.D. from Boston University and a B.S. from Morehouse College.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 386,531
Fiscal Year Total, USD 386,531

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Fuad El-Hibri

2,726,910

Daniel Abdun-Nabi

3,642,930

Robert Kramer

1,511,980

Adam Havey

1,073,360

Ronald Richard

427,566

Kathryn Zoon

--
As Of  30 Dec 2015